Posts

Showing posts with the label TDAP

Critique – GOP Export Strategy Pharmaceuticals 2023-2027 – Asrar Qureshi’s Blog Post #827

Image
Critique – GOP Export Strategy Pharmaceuticals 2023-2027 – Asrar Qureshi’s Blog Post #827 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #827 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Anna Shvets Photo Credit: Frans van Heerden Photo Credit: Tima Miroshnichenko The Export Strategy Pharmaceuticals 2023-2027 is a great step for the much-needed development of this important sector, and a good step is never too late. The identification of problems is spot on and candid in most cases. However, I would like to make the following critical comments regarding the strategy document. These issues shall impact the intended outcomes in significant ways.  Formation of Pharmaceutical Sector Specific Council A pharmaceutical s...

Travel in Africa – Part 2 – Pharma Veterans’ Blog Post #567 by Asrar Qureshi

Image
Travel in Africa – Part 2 – Pharma Veterans’ Blog Post #567 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans’ Blog Post #567. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Our first day was consumed in preparing the exhibition stall. The spaces in the designated hall were still under work and were handed over late in the evening. My colleague was doing the hard work and finally it was almost done by midnight.  Tuesday plan was to attend the 2nd Pakistan Africa Trade Conference. Chief guest was the Governor of Lagos State. Several other government officials and dignitaries were also present. From Pakistan, Advisor to PM on Commerce & Trade Abdul Razzak Dawood was there along with High Commissioner of Pakistan in Nigeria and several other offici...

Corruption in Pharmaceuticals – Sum Up – Blog Post #505 by Asrar Qureshi

Image
Corruption in Pharmaceuticals – Sum Up – Blog Post #505 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #505. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… This series is based on a report compiled by Jilian Clare Cohen1, Monique Mrazek2, and Loraine Hawkins3 for the World Bank. Our long discourse on corruption in pharmaceuticals now comes to an end. In this part we shall conclude with some recommendations. The six decision points identified by the authors of the report for the World Bank are certainly the most critical steps. There are following additional factors which let the corruption continue and/or further flourish. These factors are more relevant to developing countries like Pakistan.  Political Will W...

Tender Spots of Pharma Industry IV – Blog Post #389 by Asrar Qureshi

Image
Tender Spots of Pharma Industry IV – Blog Post #389 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #389. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here . International Business – Pakistan has a fairly developed Pharma Industry and our domestic requirement is easily fulfilled by domestic industry. We only need to import those medicines which cannot be manufactured here owing to technology reasons. Similar situation prevails in India and Bangladesh. Many other countries around us are dependent on import of medicines to varying degrees. Sri Lanka, Nepal, Bhutan, Maldives in South Asia, CIS countries from Uzbekistan to Kazakhstan, Philippines, Myanmar, Cambodia, Vietnam among ASEAN countries and almost all coun...

Post COVID Strategies – Part II – Blog Post #363 by Asrar Qureshi

Image
Post COVID Strategies – Part II – Blog Post #363 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #363. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   Continued from Previous…… In continuation with the economic impact, we talk next about stimulus packages. What was mentioned in Part I was about providing relief. Providing relief is not the same as stimulating or triggering the commercial activity. STIMULUS PACKAGES Our focus shall remain Pharma and we see what kind of stimulus packages may be considered. There is a general perception that Pharma Industry suffered less as compared to most other businesses, but this statement does not hold true when we look deeper. Pharmaceutical products may be broadly divided int...

International Marketing and Sales III – Blog Post by Asrar Qureshi

Dear Colleagues!   Today is Pharma Veterans Blog Post #119. Pharma Veterans shares your wealth of knowledge and wisdom with others for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  Please share your stories, ideas and thoughts. Please email to asrar@asrarqureshi.com for publishing your contributions here . Continued from last…… The regulatory landscape has changed rather rapidly, more than it happened at home. It is important to have a look at it. Regulatory Landscape Two key instruments have seriously impacted the regulatory environment. One is the introduction of CTD dossier and the other is Plant Inspection by Importing country. The primary motive is to discourage import from least regulated countries. And the Primary reason is protectionism. Both may be operating jointly or singly,...